The PEAD projected a Neutral outlook for $RMD after a Negative over reaction following its earnings release placing the stock in drift C.
Resmed has been on the nose of late and is very choppy in price action making it hard to navigate some analysis to buy. However, the conditions have now been met. Do you buy such a choppy price action?
ENTRY: 261.39 SL: 232.75 TP1: 307.39 TP2: 316.43 - Weekly chart - Long term trading - ADX>20 - Maintaining at pivot point "P" and 38% fib. - Strength meter is red hence some weakness. - Entry based on breakout from VZ this week.
Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series Focus: Worldwide By Sun Storm Investment Research & NexGen Wealth Management Service A Profit & Solutions Strategy & Research Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures | USA |...
Resmed has been a very steady gainer over the last 12 months. Could be worth a look.
Consolidation could be broken upwards with a minimum target in the region of 280.
Description: RMD is trending higher and in an uptrend meaning that highs are getting higher and lows are getting higher. The uptrend line on the chart and the Trending Band Indicator (which measures trend) supports the Long Position. Stats: 1. Ideal buy range: $205 - $211.2 2. Take profit: $235.09 3. Stop Loss: $199.49 4. Risk To Reward: 1 / 5 5. Accuracy Rating: 95%
Bull Flag pull back after 35% advance and bouncing of 50 MA. I like $RMD here. Resmed Inc (RMD)- DEVELOPS MEDICAL EQUIPMENT TO DIAGNOSE, MANAGE SLEEP-DISORDERED BREATHING INCLUDING OBSTRUCTIVE SLEEP APNEA
Stop: 202.00 Looking for continuation out of range. Another healthcare addition to the portfolio and a non correlated stock to the broader economy
There are a few things going on here that I think make RMD a breakout candidate. The stock is trading above its' 50 day moving average and around the 20 day moving average. A breakout should pull it well above the 20 day. The correction here was shallow, maybe even a bit too shallow at 8.7%. The base is also shallow and has just two tiers. The first tier narrows...
Long over break and hold 185 with a gap above.
ResMed (RMD): ASX down more than 4% Share prices have taken a massive fall and now approaching 78.60 Fibonacci retracement level, which is around 24.59/23.80, a critical point that could see prices bounce back and head back up. The ideal buying situation is to wait for prices to get back into the price channel at 25.88. My automated support and resistance...